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Background: Idiopathic granulomatous mastitis is a rare, benign, inflammatory chronic condition of unclear
etiology.
This case is reported because it illustrates how idiopathic granulomatous mastitis can mimic other diseases, making
it difficult to associate the presenting symptoms and the correct diagnosis; This disease is a challenge for clinicians
to diagnose, manage and avoid iatrogenic complications, and requires consultation with experts in several
specialties.
Case presentation: The patient was 30 years old, South-American, eleven weeks pregnant, and with an apparent
infectious mastitis. She presented with progressive worsening of her breast symptoms and multiple negative
laboratory tests. She suffered different side effects from several prescribed treatments and endured a prolonged
recovery. The article emphasizes the need for ruling out common pathologies to arrive at the correct diagnosis
such as bacterial and fungal infections; granulomatous conditions like tuberculosis and sarcoidosis; and
inflammatory breast carcinoma. It also describes frequently used pharmacological and supplementary forms of
treatment for patients with this condition.
Conclusion: Idiopathic granulomatous mastitis is a rare unusual condition of unknown etiology. Pathological
confirmation is required for its diagnosis and optimal management is still unclear. The presentation and
management of this case is intended to advance its awareness to physicians from different specialties.
Keywords: Granulomatous mastitis, Breast abscess, Idiopathic, Diagnosis, CorticosteroidBackground
Idiopathic granulomatous mastitis (IGM) is an uncom-
mon, benign, inflammatory chronic condition of unclear
etiology [1]. A 2011 review article reported 541 cases since
1972 [2]. It is also known as granular lobular mastitis and
usually poses a diagnostic and therapeutic dilemma [3]. It
is a relatively recent reported condition that was first des-
cribed in 1972 by Kessler and Wollock [4]. The primary
presentation is a firm breast mass, frequently associated
with local pain and eventually skin ulcerations, abscesses
and fistulae develop [3,5]. The clinical presentation fre-
quently mimics breast abscess, infective mastitis and
breast cancer [6]. Histopathological study is required to
make the diagnosis, and findings include noncaseating* Correspondence: jagarcia@ucalgary.ca
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other granulomatous diseases.
Definitive treatment has not yet been defined [7].
Treatment most frequently includes corticosteroids [8]
and immunosuppressants [2], although colchicine has
been used [3]. Management can sometimes require dras-
tic measures such as mastectomy [1,9].
Review articles aim to clarify the diagnosis and man-
agement [2,5,7,9] and most authors debate the suitability
of either conservative or surgical treatment [1].
Case presentation
A 30-year-old Colombian woman, G3,P1,A1, who was in
her 11th week of an uneventful pregnancy, complained
of one week of severe breast pain and had noted a small
breast lump. She reported no signs of infection. She had
breast fed her last baby eight months earlier. Her me-
dical and surgical history was unremarkable, with no his-
tory of tuberculosis exposure and she had receivedBioMed Central Ltd. This is an Open Access article distributed under the terms
(http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 A photograph of the patient’s left breast. Clinical
appearance of the patient’s breast including skin ulcerations,
abscesses and fistulae. Photo obtained at the end of her first
hospital admission.
Figure 2 Histology slide 1 of the patient’s left breast specimen.
Granulomatous inflammation with microabscess is observed,
showing a granuloma with two giant cells and central inflammation.
This sample was obtained by true-cut biopsy during her first
hospital admission.
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taken contraceptives. Her family history was negative for
breast cancer.
On physical examination a 3 cm. tender mass was
palpated over the superior-external quadrant of her left
breast with mild erythema. Her temperature was normal.
A breast ultrasound was ordered.
Five days later her mass had grown to 9 cm. and was
extremely tender to palpation; She was febrile (37.7°C).
She was started on cephalexin and acetaminophen. On
the 10th day, the ultrasound reported mastitis, with a
macrolobulated focus and an area of possible fat necrosis
around it. Her mass was now 12 cm. and a second 5 cm.
mass had appeared.
She was urgently referred for drainage, which was
attempted transcutaneously and was unsuccessful. Her
pain became intolerable and during the following one
and a half months she required two hospital admissions.
Consultation and management were provided by physi-
cians in internal medicine, emergency medicine, general
surgery, gynecology, infectious diseases (including tuber-
culosis specialists), pathology, radiology and initial diagno-
ses made by these consultants included mastitis, breast
abscess, breast carcinoma and tuberculous mastitis.
Cultures of breast tissue initially reported scant
Haemophilus influenzae and Streptococcus viridians, and
the patient was treated sequentially with clindamycin,
cefazolin, vancomycin, piperacillin-tazobactam combin-
ation, ceftriaxone and metronidazole with no improve-
ment, and narcotics were required to control her pain.
After the first dose of vancomycin the patient developed
drowsiness, shortness of breath, a generalized rash and
fever of 40.8 C degrees. She was diagnosed of having an
atypical “red man” syndrome, from which she recovered
uneventfully. She also had an allergic reaction to clin-
damycin. Chest radiographs demonstrated a calcified left
upper lobe pulmonary granuloma. At the end of that
month, incision and drainage was performed twice, with
multiple biopsy samples obtained. Further bacterial
cultures, fungal cultures and tuberculosis cultures and
stains were negative. While undergoing these treat-
ments the breast lesions progressed to involve most of
the left breast, skin fistulae formed, thick material exuded
from the surgical drains (Figure 1) and the patient
remained febrile. The pathology reports noted granu-
lomatous inflammation with plasma cells, giant cells,
macrophages, lymphocytes and a single granuloma with
central necrosis, and ruled out breast carcinoma
(Figures 2 and 3). At the end of her hospitalization
period the final diagnosis was IGM, the patient was
started on prednisone 20 mg. four times daily, and some
improvement of symptoms occurred. This medication
dose varied from 60 mg. four times daily to 15 mg. daily
based on her evolution.
Figure 3 Histology slide 2 of the patient’s left breast specimen.
Acute mastitis with polymorphonuclear cells within a terminal duct
lobular unit.
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more tolerable, and she had a normal vaginal delivery at
40 weeks. She breast-fed her baby with her right breast
for two months. She continued prednisone treatment on
the same variable doses. Her left breast continued to
have scattered areas of drainage and new areas of ten-
derness developed.
One month after her delivery treatment options were
re-considered by a multidisciplinary team and due to the
deterioration in her symptoms a mastectomy was re-
commended. The patient disagreed with the decision,
and returned to Colombia to obtain further opinions.
In Colombia she was treated with minocycline for six
months and two 10 day cycles of IV amikacin. Deflazacort
was given to control local inflammatory relapses. Triam-
cinolone and amikacin injections were given to the inflam-
matory nodules. The discharge from her lesions stopped
six months after starting this treatment and the induration
and redness disappeared one month later. She returned to
Canada and continued taking only deflazacort, varying its
dose depending on the presence of side effects. One year
later, her symptoms and lesions had been controlled but,
decreasing her deflazacort dose led to reappearance of
discomfort and redness. The patient maintained her 6 mg.
dose for four months remaining asymptomatic, at which
time, she decided to stop her medication completely. Her
lesions never returned and she has been asymptomatic
until now.Discussion
This IGM case demonstrates potential difficulties in
diagnosis and management, iatrogenic complications,the need to involve different areas of expertise, and the
absence of knowledge about the etiology of IGM.
IGM is a relatively recent reported condition which was
first described in 1972 by Kessler and Wollock [4]. It has
also been called granular lobular mastitis by Going et al
since 1987, based on histological samples that had a
lobule-centered distribution from patients with the disease
[10]. It is a rare, benign, inflammatory chronic condition
of unclear etiology. The primary presentation is a firm
breast mass, which is tender. It has been reported that up
to 25% of cases can involve both breasts [1]. The full pres-
entation includes breast masses, tumorous indurations,
skin ulcerations, inflammation, local pain, tenderness, ga-
lactorrhea, abscesses and fistulae. Some authors have sug-
gested that IGM is a self-limiting condition [1], with a
range of two to 24 months [9] but a chronic presentation
could last for several years.
IGM is seen more frequently in premenopausal
women, but the age of presentation can widely vary. It
has been reported in an 11 year old girl [7] as well as
cases in the 6th, 7th and 8th decades [6]. Associations
have been suggested with breast feeding, use of contra-
ceptives, autoimmune disorders, alpha-1 antitrypsin defi-
ciency and hyperprolactinemia [5,8]. Diagnostic tools
such as ultrasound, mammogram, true-cut biopsy, fine
needle aspiration biopsy and contrast-enhanced MRI can
be helpful in diagnosis. A true-cut biopsy is recom-
mended to clarify the diagnosis [11]. Other entities such
us malignancy, fungal, bacterial and parasitic infections,
autoimmune conditions, and other granulomatous di-
seases such as tuberculosis and sarcoidosis should be
excluded. The diagnostic histopathologic changes include
chronic granulomatous lobulitis without caseating necro-
sis plus giant cells, leucocytes, epitheloid cells, macro-
phages and micro-abscesses.
IGM is usually a diagnostic and therapeutic dilemma,
which initially can mimic other conditions and is a diagno-
sis of exclusion. The clinical presentation frequently sug-
gests breast abscess or breast cancer [9,12]. Some authors
have mentioned that more than 50% of cases can mimic
breast carcinoma [7]. The patient reported in this article
started her clinical picture with unspecific findings of an
expanding mass and surrounding local inflammation, as is
usually described [5,8]. As with most patients with IGM the
initial presentation leads to the use of antibiotics. In this pa-
tient, symptoms developed to suggest an infective mastitis
or possibly an abscess. As her condition worsened, empiric
antibiotic treatment was started.
When the diagnosis suggests mastitis, the lack of
response in patients suffering from this condition can
lead to different antibiotic combinations and the uncer-
tain treatment could lead to complications, as was the
case of this patient (“Red man” syndrome and allergic
reaction to Clindamycin).
Garcia-Rodiguez and Pattullo BMC Research Notes 2013, 6:95 Page 4 of 4
http://www.biomedcentral.com/1756-0500/6/95As the study of patients with this clinical presentation
requires exclusion of other causes of mastitis and malig-
nancy, obtaining core specimens by true-cut biopsy for
pathological study is paramount. In this case, the path-
ology ruled out neoplasms but reported abscesses with
positive bacterial cultures leading to antibiotic treat-
ments. However, the presence of a granuloma and giant
cells suggested IGM. Having a granuloma with central
necrosis and evidence of a calcified pulmonary nodule
on x-ray made tuberculosis a possible etiology, but the
different cultures and stains were always negative for tu-
berculosis and her previous history was noncontributory
for this diagnosis.
In the case presented, the patient emphatically refused to
accept the radical surgical treatment that was proposed to
her, her tenacity made her maintain her wish for conserva-
tive management, and her desperation lead her to look for
further treatment in Colombia that helped to stabilize her
situation. There is still debate about the treatment for this
condition but it should initially be non-operative [1,5].
Conservative treatment with close observation has been
suggested. In most of the cases once infectious conditions
have been excluded oral steroid therapy is required [1,8].
Most of the evidence that supports these interventions
comes from original articles and case reports. Anti-
inflammatory medications, systemic antibiotics, methotrex-
ate, colchicine, local infiltrations and ulcers wound care are
also helpful. One study documented relapse in 50% of
cases after discontinuing corticosteroid treatment. In those
refractory to treatment or which recur, methotrexate or
azathioprine are recommended [2]. In more difficult cases
immunosuppressive management and complete surgical
excision can be considered [6].
Conclusions
A high index of suspicion is required to make the
diagnosis the diagnosis of IGM. During the diagnostic
process is important to rule out invasive carcinoma,
breast infections and other granulomatous conditions.
Treatment will remain a challenge in the absence of
more specific disease understanding and optimal deci-
sions for care will often draw on the judgment of clini-
cians from many areas of expertise.
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